Four Years After Disrupting Clinical Trial Diversity at DPHARM, Acclinate Is Back to Disrupt the Data Behind It

The company that modernized how clinical research reaches underserved communities is back at DPHARM with a new platform built to revolutionize how pharmaceutical companies understand and act on community data BIRMINGHAM, Ala., Sept. 14, 2026 /PRNewswire/ -- In 2022, Acclinate stepped onto...